These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7271270)

  • 1. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
    Grimm H
    Infection; 1979; 7(5):256-9. PubMed ID: 389806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
    Yokota Y; Murakawa T; Nishida M
    J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosfomycin, antimicrobial activity in vitro and in vivo.
    Goto S
    Chemotherapy; 1977; 23 Suppl 1():63-74. PubMed ID: 401721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1982 Oct; 22(4):560-3. PubMed ID: 7181471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A; Walder M
    J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of susceptibilities for fosfomycin determined by various methods in clinical isolates in 2003 -2004].
    Muramatsu H; Ishikawa J; Nagura O; Horii T
    Jpn J Antibiot; 2007 Apr; 60(2):107-24. PubMed ID: 17612258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jul; 22(1):23-7. PubMed ID: 6214995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.
    Nakamura G; Wachino J; Sato N; Kimura K; Yamada K; Jin W; Shibayama K; Yagi T; Kawamura K; Arakawa Y
    J Clin Microbiol; 2014 Sep; 52(9):3175-9. PubMed ID: 24951800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro effect of fosfomycin against Pseudomonas aeruginosa compared to carbenicillin, gentamycin and polymyxin B].
    Ansorg R
    Infection; 1978; 6(2):73-7. PubMed ID: 418008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.